Stock listing

KRX:003000 Bukwang Pharmaceutical Co., Ltd. (부광약품) 주가

Follow Bukwang Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.

Share price · KRX:003000

₩3,800.00 KRW -65.00 (-1.7%)

Close on Nov 20, 2026

Past year -1.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩3,760.00 – ₩3,865.00 KRWNov 20, 2026
Volume
242,575 sharesNov 20, 2026
Market cap
₩374.9B KRWAt the close on Nov 20, 2026 · price × 98.66M shares outstanding
52-week range
₩3,580.00 – ₩9,890.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩1.64B KRWMedian day 221,381 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Bukwang Pharmaceutical Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:003000 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩3,800.00-65.00-1.7%₩3,820.00₩3,865.00₩3,760.00242,575
₩3,865.00-5.00-0.1%₩3,865.00₩3,990.00₩3,755.00217,124
₩3,870.00-20.00-0.5%₩3,860.00₩3,950.00₩3,830.00172,763
₩3,890.00-95.00-2.4%₩4,020.00₩4,020.00₩3,865.00121,798
₩3,985.00+35.00+0.9%₩3,960.00₩4,065.00₩3,940.00159,315
₩3,950.00-125.00-3.1%₩4,075.00₩4,110.00₩3,925.00175,789
₩4,075.00+70.00+1.7%₩3,995.00₩4,135.00₩3,985.00396,821
₩4,005.00+180.00+4.7%₩3,825.00₩4,010.00₩3,825.00257,906
₩3,825.00+25.00+0.7%₩3,820.00₩3,940.00₩3,795.00401,155
₩3,800.00-55.00-1.4%₩3,810.00₩3,880.00₩3,705.00422,806
₩3,855.00+15.00+0.4%₩3,830.00₩3,940.00₩3,815.00379,860
₩3,840.00+155.00+4.2%₩3,790.00₩3,840.00₩3,675.00300,317
₩3,685.00-10.00-0.3%₩3,710.00₩3,730.00₩3,630.00210,591
₩3,695.00+25.00+0.7%₩3,630.00₩3,730.00₩3,630.00134,799
₩3,670.00-30.00-0.8%₩3,665.00₩3,750.00₩3,625.00255,548
₩3,700.00-50.00-1.3%₩3,750.00₩3,765.00₩3,640.00225,637
₩3,750.00-5.00-0.1%₩3,780.00₩3,795.00₩3,730.00214,340
₩3,755.00+95.00+2.6%₩3,690.00₩3,755.00₩3,655.00413,197
₩3,660.00-140.00-3.7%₩3,700.00₩3,795.00₩3,660.00191,636
₩3,800.00-65.00-1.7%₩3,835.00₩3,915.00₩3,740.00255,240
₩3,865.00-25.00-0.6%₩3,890.00₩3,930.00₩3,815.00135,073
₩3,890.00-25.00-0.6%₩3,940.00₩4,020.00₩3,880.00166,934
₩3,915.00-30.00-0.8%₩3,905.00₩3,995.00₩3,875.00147,574
₩3,945.00+45.00+1.2%₩3,890.00₩3,950.00₩3,835.00181,716
₩3,900.00+220.00+6.0%₩3,685.00₩3,970.00₩3,685.00337,495
₩3,680.00-155.00-4.0%₩3,795.00₩3,795.00₩3,635.00470,646
₩3,835.00-75.00-1.9%₩3,910.00₩3,970.00₩3,815.00199,359
₩3,910.00-10.00-0.3%₩3,860.00₩4,025.00₩3,775.00673,866
₩3,920.00-135.00-3.3%₩4,055.00₩4,095.00₩3,915.00393,517
₩4,055.00-215.00-5.0%₩4,205.00₩4,225.00₩3,900.00448,548
₩4,270.00+120.00+2.9%₩4,215.00₩4,785.00₩4,155.002,523,490
₩4,150.00+50.00+1.2%₩4,150.00₩4,200.00₩4,085.00275,741
₩4,100.00-55.00-1.3%₩4,165.00₩4,230.00₩4,080.00207,832
₩4,155.00+135.00+3.4%₩4,050.00₩4,155.00₩4,020.00333,678
₩4,020.00+50.00+1.3%₩4,025.00₩4,070.00₩3,975.00146,673
₩3,970.00-40.00-1.0%₩3,965.00₩4,010.00₩3,950.00103,251
₩4,010.00+80.00+2.0%₩3,970.00₩4,065.00₩3,925.00204,083
₩3,930.00-5.00-0.1%₩3,990.00₩4,000.00₩3,930.0091,081
₩3,935.00-85.00-2.1%₩4,020.00₩4,045.00₩3,935.00178,294
₩4,020.00+15.00+0.4%₩4,020.00₩4,020.00₩3,945.00149,283
₩4,005.00+70.00+1.8%₩3,975.00₩4,040.00₩3,960.00249,305
₩3,935.00+5.00+0.1%₩3,885.00₩3,980.00₩3,885.00162,591
₩3,930.00+85.00+2.2%₩3,860.00₩3,940.00₩3,820.00188,457
₩3,845.00-45.00-1.2%₩3,895.00₩3,975.00₩3,825.00653,745
₩3,890.00-80.00-2.0%₩3,970.00₩3,975.00₩3,845.00724,090
₩3,970.00-120.00-2.9%₩4,050.00₩4,095.00₩3,930.00873,298
₩4,090.00-35.00-0.8%₩4,110.00₩4,125.00₩4,025.00193,799
₩4,125.00+50.00+1.2%₩4,080.00₩4,125.00₩4,075.00207,136
₩4,075.00-30.00-0.7%₩4,130.00₩4,195.00₩4,070.00268,075
₩4,105.00+25.00+0.6%₩4,130.00₩4,195.00₩4,080.00317,390
₩4,080.00+40.00+1.0%₩4,050.00₩4,155.00₩4,020.00348,392
₩4,040.00-25.00-0.6%₩4,075.00₩4,165.00₩4,030.00459,074
₩4,065.00-315.00-7.2%₩4,380.00₩4,545.00₩4,065.001,166,636
₩4,380.00+195.00+4.7%₩4,190.00₩4,875.00₩4,140.004,811,517
₩4,185.00-15.00-0.4%₩4,235.00₩4,235.00₩4,085.00132,573
₩4,200.00+30.00+0.7%₩4,150.00₩4,220.00₩4,105.00134,897
₩4,170.00-40.00-1.0%₩4,210.00₩4,215.00₩4,100.00167,055
₩4,210.00+60.00+1.4%₩4,200.00₩4,215.00₩4,120.00162,469
₩4,150.00-5.00-0.1%₩4,155.00₩4,155.00₩3,970.00169,067
₩4,155.00+25.00+0.6%₩4,135.00₩4,225.00₩4,090.00153,432
₩4,130.00-160.00-3.7%₩4,250.00₩4,255.00₩4,070.00296,730
₩4,290.00+90.00+2.1%₩4,395.00₩4,820.00₩4,285.00562,046

Splits

12 splits since 2007 · KRX:003000 · every price before a split is adjusted for it

DayRatioWhat
11-for-10Split
21-for-20Split
13-for-10Split
11-for-10Split
6-for-5Split
11-for-10Split
11-for-10Split
21-for-20Split
21-for-20Split
21-for-20Split
21-for-20Split
21-for-20Split
Ticker
KRX:003000
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
KRX
Currency
KRW

What changed lately

Latest news

All Bukwang Pharmaceutical Co., Ltd. news

Bukwang Pharmaceutical Co., Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
1 in the last 12 months · 2 in all · newest Apr 21, 2026 · oldest 2025

Valuation

P/E 42.7× against a median of 41.2×: 3rd lowest of 4 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩205.8B KRW
P/E
42.7×
EV/sales
1.0×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
1.1×
Gross margin
44.5%
Operating margin
5.4%
Net margin
4.1%
Debt to equity
0.0×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Bukwang Pharmaceutical Co., Ltd. · KRX:003000US$278.7MUS$153.0M42.7×1.0×n/a1.1×4.1%0.0×n/a
ARS Pharmaceuticals, Inc. · NASDAQ:SPRYUS$297.6MUS$281.0Mn/a2.3×n/an/a−163.6%n/a2.09
Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A · SSE:605199US$287.7MUS$344.3Mn/a3.8×n/a7.2×−68.9%1.5×n/a
Chengdu Huasun Technology Group Inc., Ltd. Class A · SZSE:000790US$285.5MUS$277.5Mn/a4.4×n/a2.7×−57.2%0.1×n/a
Tiansheng Pharmaceutical Group Co. Ltd. Class A · SZSE:002872US$279.7MUS$239.5Mn/a3.1×n/a1.0×−10.6%0.0×n/a
Ildong Pharmaceutical Co., Ltd. · KRX:249420US$278.0MUS$233.1M8.6×0.5×6.3×1.4×7.5%0.0×n/a
Deva Holding A.S. · BIST:DEVAUS$276.9MUS$245.0Mn/a0.6×4.4×0.4×−3.9%0.1×n/a
Honz Pharmaceutical Co., Ltd. Class A · SZSE:300086US$276.0MUS$298.2Mn/a5.9×n/a2.2×−62.4%0.2×n/a
Shandong Sito Bio-technology Co., Ltd. Class A · SZSE:300583US$272.2MUS$254.6M62.3×1.5×n/a1.0×2.6%0.1×n/a
Lavipharm SA · ATHEX:LAVIUS$271.0MUS$309.0M41.2×4.5×22.8×4.4×9.6%0.7×n/a
Zhejiang East Asia Pharmaceutical Co., Ltd. Class A · SSE:605177US$264.1MUS$340.3Mn/a2.4×n/a1.1×−21.8%0.5×n/a
Median of the othersUS$277.5MUS$279.2M41.2×2.8×6.3×1.4×−16.2%0.1×2.09

Events

QuarterResultsShare move
Q1 2026Apr 20, 2026 · Before open−3.0%
Q3 2025Oct 20, 2025 · Before open+1.0%
Q1 2025Apr 21, 2025 · After close+0.3%
Q4 2024Feb 6, 2025 · Before open+0.5%
Q3 2024Oct 22, 2024 · After close+1.2%
Q2 2024Aug 13, 2024 · Before open−2.5%
Q1 2024Apr 23, 2024 · After close+1.0%
Q4 2023Feb 29, 2024 · Before open0.0%
Q3 2023Nov 13, 2023 · After close−0.7%
Q2 2023Aug 10, 2023+0.7%
All 19 quarters
QuarterResultsShare move
Q1 2023May 15, 2023 · Before open−0.5%
Q4 2022Jan 31, 2023 · Before open+2.2%
Q3 2022Nov 11, 2022 · Before open+2.2%
Q2 2022Aug 15, 2022 · After close−0.5%
Q1 2022May 13, 2022 · Before open+3.9%
Q3 2021Nov 12, 2021 · Before open+3.2%
Quarter to Jun 30, 2021Aug 13, 2021 · Before open−2.9%
Quarter to Mar 31, 2021May 14, 2021 · Before open−0.5%
Quarter to Dec 31, 2020Mar 11, 2021 · After close+0.4%

Open Events

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue200.7B160.1B125.9B190.9B182.5B169.7B168.2B194.2B150.7B138.6B
Cost of revenue108.8B85.7B78.9B111.5B106.7B98.0B83.9B79.2B70.1B62.3B
Gross profit91.9B74.3B47.1B79.4B75.8B71.6B84.2B115.0B80.6B76.3B
Research and development19.4B23.4B34.6B24.3B22.5B18.0B17.3B24.6B25.1B18.7B
Selling, general and administrative24.8B16.8B22.1B19.8B13.5B15.3B22.2B20.1B16.5B18.7B
Operating income14.2B1.62B-37.5B-230.6M5.62B4.03B9.54B35.1B7.68B8.54B
Depreciation and amortization5.49B4.11B4.29B5.12B4.84B6.16B5.84B6.88B6.10B5.70B
EBITDA19.7B5.72B-33.2B4.89B10.5B10.2B15.4B42.0B13.8B14.2B
Interest expense3.90B6.49B3.81B1.76B1.41B1.51B90.9M000
Income before tax6.39B-2.97B-39.6B-1.03B3.79B-8.30B-1.36B191.1B14.9B21.0B
Income tax6.58B1.81B6.07B45.4B3.79B5.22B
Net income12.6B-2.64B-31.3B-2.47B-916.6M-7.20B-7.41B145.7B11.1B15.8B
Earnings per share, basic127.28-35.43-457.67-33.19-13.39-115.71-110.562,580.74171.54

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents96.2B90.1B151.2B85.5B82.8B79.3B37.6B100.4B24.2B41.1B
Short-term investments120.0B40.0B1.50B10.3B
Receivables27.8B23.6B35.7B88.0B90.4B103.7B103.0B86.6B60.2B50.3B
Inventory52.2B41.7B56.8B38.6B39.3B51.4B44.1B34.2B39.6B39.4B
Current assets303.2B203.7B254.2B218.7B220.1B248.2B186.4B221.6B124.3B134.0B
Property, plant and equipment124.5B106.3B128.8B128.5B60.2B60.9B
Goodwill0406.6M878.7M834.5M828.7M827.0M796.8M786.5M788.9M782.7M
Total assets476.3B373.2B429.0B400.9B397.4B401.0B388.5B493.6B236.2B237.6B
Accounts payable7.30B5.06B2.37B16.5B7.42B10.2B9.89B4.34B4.68B3.28B
Current liabilities117.8B35.4B97.5B44.6B37.0B61.2B35.9B38.2B19.2B16.8B
Long-term debt79.0B78.5B
Total liabilities135.4B129.0B194.8B129.1B117.4B129.8B62.0B80.2B24.9B23.0B
Shareholders' equity340.6B243.7B226.3B263.2B269.6B258.5B326.2B413.4B211.3B214.6B
Shares outstanding98.7M74.6M68.5M74.6M68.5M62.3M67.0M56.4M64.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations21.5B34.4B-9.36B16.5B26.5B723.2M-23.4B6.82B8.56B-7.76B
Capital spending-11.2B-2.61B-2.83B-4.99B-785.1M-1.92B-3.54B-3.71B-4.49B-5.93B
Free cash flow10.3B31.7B-12.2B11.5B25.7B-1.23B-28.3B3.09B2.03B-13.7B
Cash from investing4.75B13.0B18.1B35.0B-7.45B3.59B
Cash from financing-27.5B28.2B-57.5B34.5B-18.0B-22.3B
Dividends paid-4.93B-6.85B-6.23B-12.2B-9.77B-8.61B-17.9B-22.8B
Share buybacks-2.75B-516.2M-25.1B-50.2B-110.0M-80.3M-87.1M
Change in cash6.12B-61.1B65.7B2.74B3.49B41.7B-62.8B76.2B-16.9B-26.4B

Open Financials

Cap table

Built by 6ix from Bukwang Pharmaceutical Co., Ltd.’s releases

Common shares
98,664,671
Fully diluted
98,664,671

Fully diluted

LineShares
Common shares98,664,671

Share count over time

CountShares
Nov 22, 202698,664,671

Open Cap table

Shareholders

HolderSharesValueChangeAs of
Vanguard Total International Stock Index Fund1.04MUS$2.88MNo changeJul 31, 2026
Vanguard Developed Markets Index Fund734KUS$2.04MNo changeJun 30, 2026
Dimensional Emerging Markets Value Fund242KUS$669K+159KJul 31, 2026
Emerging Markets Core Equity 2 Portfolio235KUS$650KNo changeJul 31, 2026
Schwab International Small-Cap Equity ETF155KUS$500K−23,634May 31, 2026
Vanguard Pacific Stock Index Fund81,820US$227KNo changeJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF65,146US$182K+5,908Jul 31, 2026
The Emerging Markets Small Cap Series63,644US$176K+12,542Jul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF63,394US$175K−64Jun 30, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund60,581US$168K−209KJul 31, 2026
All 23 holders
HolderSharesValueChangeAs of
Dimensional Emerging Core Equity Market ETF59,965US$168KNo changeJul 31, 2026
Vanguard Total World Stock Index Fund56,055US$155KNo changeJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF48,796US$137K+24,809Jul 31, 2026
State Street(R) SPDR(R) S&P(R) International Small Cap ETF26,827US$74,111No changeJun 30, 2026
World ex U.S. Core Equity Portfolio20,399US$56,486+10,774Jul 31, 2026
Avantis Emerging Markets Equity ETF19,091US$61,470No changeMay 31, 2026
Emerging Markets ex China Core Equity Portfolio16,056US$44,460+6,809Jul 31, 2026
Emerging Markets Social Core Equity Portfolio10,134US$28,061+253Jul 31, 2026
Vanguard ESG International Stock ETF9,336US$30,060No changeMay 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF8,361US$23,399No changeJul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio6,244US$17,290No changeJul 31, 2026
Avantis Emerging Markets Equity Fund694US$2,235No changeMay 31, 2026
Dimensional Emerging Markets ex China Core Equity ETF97US$271No changeJul 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Bukwang Pharmaceutical Co., Ltd.